Author:
Gamucci T.,Vaccaro A.,Ciancola F.,Pizzuti L.,Sperduti I.,Moscetti L.,Longo F.,Fabbri M. A.,Giampaolo M. A.,Mentuccia L.,Di Lauro L.,Vici P.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference36 articles.
1. Amar S, McCullough AE, Tan W et al (2010) Prognosis and outcome of small (≥1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status. Oncologist 15:1043–1049
2. Banerjee S, Smith IE (2010) Management of small HER2-positive breast cancers. Lancet Oncol 11:1193–1199
3. Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC (2009) Early breast cancer. Lancet 373:1463–1479
4. Black D, Younger J, Martei Y et al (2006) Recurrence risk in T1a-b, node negative, HER2 positive breast cancer. [abstract 2037]. Breast Cancer Res Treat 100:S92
5. Buzdar AU, Ibrahim NK, Francis D, Booser DJ et al (2005) Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2 positive operable breast cancer. J Clin Oncol 23:3676–3685
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献